Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	18 fdg	-	-	-	-	[1] 145 💬
2	Acetate	Acetate	-	-	-	[43]  1 ,  2 ,  6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬
3	Acth	Corticotropin	[1] D00146 💬	[1] MC2R 💬	[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway	[5] 13, 66, 145, 193, 222 💬
4	Adrenocorticotropin hormone	-	-	-	-	[1] 145 💬
5	Cannabidiol	Cannabidiol	[1] D10915 💬	[2] CNR1, CNR2 💬	[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis	[17]  6 ,  8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271 💬
6	Cannabidiol (cbd)	Cannabidiol	[1] D10915 💬	[2] CNR1, CNR2 💬	[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis	[6]  6 , 140, 144, 145, 156, 158 💬
7	Cannabidiol oral solution	Cannabidiol	[1] D10915 💬	[2] CNR1, CNR2 💬	[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis	[4] 140, 144, 145, 193 💬
8	Cbd	-	-	-	-	[11]  2 ,  6 ,  8 , 13, 46, 140, 144, 145, 156, 158, 206 💬
9	Combination therapy with vigabatrin and prednisolone	Prednisolone	[9] D00472, D00535, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	[2] ABAT, NR3C1 💬	[8] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism	[1] 145 💬
10	Cosyntropin	Tetracosactide	[1] D00284 💬	[1] MC2R 💬	[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway	[3] 83, 113, 145 💬
11	Cosyntropin injectable suspension 1 mg/ml + vigabatrin	Tetracosactide	[2] D00284, D00535 💬	[2] ABAT, MC2R 💬	[12] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway	[1] 145 💬
12	Cosyntropin injectable suspension, 1 mg/ml	Tetracosactide	[1] D00284 💬	[1] MC2R 💬	[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway	[1] 145 💬
13	Decortin h	-	-	-	-	[3] 66, 97, 145 💬
14	Fenfluramine	Fenfluramine	[1] D07945 💬	[4] HTR2A, HTR2B, HTR2C, SLC6A4 💬	[6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle	[3] 140, 144, 145 💬
15	Ganaxolone	Ganaxolone	[1] D04300 💬	[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬	[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction	[4] 145, 152, 158, 206 💬
16	Gwp42003-p	-	-	-	-	[5] 140, 144, 145, 156, 158 💬
17	Intravenous methylprednisolone	Methylprednisolone	[6] D00407, D00751, D00979, D05000, D05001, D05002 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[2] 13, 145 💬
18	Jbpos0101	JBPOS0101	-	-	-	[1] 145 💬
19	M071754	-	-	-	-	[1] 145 💬
20	Melatonin	Melatonin	[1] D08170 💬	[2] MTNR1A, MTNR1B 💬	[2] Circadian entrainment, Neuroactive ligand-receptor interaction	[11]  6 ,  8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬
21	Methylprednisolone	Methylprednisolone	[6] D00407, D00751, D00979, D05000, D05001, D05002 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[44]  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
22	Modified atkins diet	-	-	-	-	[2] 145, 157 💬
23	Null	-	-	-	-	[16]  6 , 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬
24	Oral pednisolone	-	-	-	-	[1] 145 💬
25	Oral prednisolone	Prednisolone	[8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[2] 49, 145 💬
26	Other: modified atkins diet	-	-	-	-	[1] 145 💬
27	Prednisolone	Prednisolone	[8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[40] 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
28	Pyridoxine	Pyridoxine	[2] D02179, D08454 💬	-	-	[2] 93, 145 💬
29	Pyridoxine plus prednisolone	Prednisolone	[10] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02179, D03301, D08454 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 145 💬
30	Radiprodil	Radiprodil	-	-	-	[1] 145 💬
31	Sabril	-	-	-	-	[1] 145 💬
32	Sabril granules for oral use	-	-	-	-	[1] 145 💬
33	Sabril sachets	-	-	-	-	[1] 145 💬
34	Sabrilex	-	-	-	-	[1] 145 💬
35	Sabril®	-	-	-	-	[1] 145 💬
36	Soluble prednisolone tablets	Prednisolone	[8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 145 💬
37	Spt3162	-	-	-	-	[1] 145 💬
38	Synacthen depot	-	-	-	-	[3] 83, 145, 222 💬
39	Tetracosactide	Tetracosactide	[1] D00284 💬	[1] MC2R 💬	[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway	[4] 83, 113, 145, 222 💬
40	Tetracosactide acetate	Acetate	[1] D00284 💬	[1] MC2R 💬	[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway	[2] 83, 145 💬
41	Ucb3491	-	-	-	-	[1] 145 💬
42	Vgb-st	-	-	-	-	[1] 145 💬
43	Vgb-st soluble tablets	-	-	-	-	[1] 145 💬
44	Vigabatrin	Vigabatrin	[1] D00535 💬	[1] ABAT 💬	[7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism	[2] 145, 158 💬
45	Vigabatrin tablets	Vigabatrin	[1] D00535 💬	[1] ABAT 💬	[7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism	[1] 145 💬
46	Vigabatrin: vigabatrin new st formulation then sabril®	Vigabatrin	[1] D00535 💬	[1] ABAT 💬	[7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism	[1] 145 💬

Back to top